Authors:
SCHULLER J
CZEJKA M
BANDAK S
BOROW D
PIETRZAK C
MAREI I
SCHERNTHANER G
Citation: J. Schuller et al., COMPARISON OF PHARMACOKINETICS (PK) OF FREE AND LIPOSOME-ENCAPSULATEDDOXORUBICIN IN ADVANCED CANCER-PATIENTS, European journal of cancer, 31A, 1995, pp. 959-959
Authors:
CZEJKA M
BANDAK S
SIMON D
SCHULLER J
WEISS C
SCHERNHAMMER E
Citation: M. Czejka et al., PHARMACOKINETIC INTERACTION BETWEEN 4'-EPIDOXORUBICIN AND THE MULTIDRUG-RESISTANCE REVERTING AGENT QUININE, Zeitschrift fur Naturforschung. C, A journal of biosciences, 50(7-8), 1995, pp. 565-570
Authors:
CZEJKA MJ
SCHULLER J
WEISS C
BANDAK S
MEYER B
SIMON D
Citation: Mj. Czejka et al., DISPOSITION OF 5-FORMYLTETRAHYDROFOLIC AND 5-METHYLTETRAHYDROFOLIC ACID IN SERUM AFTER IV BOLUS OF CALCIUM FOLINATE - PHARMACOKINETIC DRUG-INTERACTION WITH PREADMINISTERED INTERFERON-ALPHA-2B, European journal of drug metabolism and pharmacokinetics, 20(4), 1995, pp. 255-262
Authors:
CZEJKA M
SCHULLER J
SCHERNHAMMER E
BANDAK S
Citation: M. Czejka et al., DRUG-INTERACTION BETWEEN INTERFERON-ALPHA -2B AND 5-FLUOROURACIL DURING CONTINUOUS INTRAVENOUS 5FU-INFUSION, Die Pharmazie, 50(6), 1995, pp. 416-419
Authors:
BANDAK S
CZEJKA M
SCHULLER J
SCHERNHAMMER E
Citation: S. Bandak et al., PHARMACOKINETIC DRUG-INTERACTION BETWEEN EPIRUBICIN AND INTERFERON-A-2B IN SERUM AND RED-BLOOD-CELLS, Arzneimittel-Forschung, 45-1(2), 1995, pp. 212-215
Citation: S. Bandak et al., IN-VITRO AND IN-VIVO BINDING OF EPIRUBICIN TO RED-BLOOD-CELLS AND HUMAN PLASMA-PROTEINS, Zeitschrift fur Naturforschung. C, A journal of biosciences, 49(7-8), 1994, pp. 483-488